Enhancing effects of tilorone on collagen arthritis and humoral immune response to type II collagen.
The effect of tilorone, which is known to suppress adjuvant arthritis, on the induction of collagen arthritis in rats was investigated. Combined data of the present experiments show that all of the tilorone-treated rats except one in the lowest dosage group developed arthritis but that the incidence of arthritis in the tilorone-treated groups was not significantly different from that of the control group. The results also show that the two higher dosages (12.5 and 25 mg/kg/day) of tilorone caused a significant increase in the severity of collagen arthritis. Humoral immune response to type II collagen was significantly augmented in these two higher dosage groups; however, delayed-type hypersensitivity response to type II collagen was suppressed while tilorone was administered continuously. In addition, treatment with tilorone caused a significant increase in the concentration of anticollagen IgG extractable from the joint tissue. Anticollagen IgG subclass analysis revealed that the major subclass was IgG2a in both the serum and paw extract, with minor amounts of IgG2b, IgG2c, and IgG1. The response of all these subclasses was almost equally activated by tilorone treatment.
D000818:Animals; D000917:Antibody Formation; D001168:Arthritis / Q000209:etiology*; D001169:Arthritis, Experimental / Q000209:etiology* / Q000276:immunology; D003094:Collagen / Q000276:immunology*; D005260:Female; D005449:Fluorenes / Q000494:pharmacology*; D006968:Hypersensitivity, Delayed; D007074:Immunoglobulin G / Q000032:analysis; D051381:Rats; D013994:Tilorone / Q000494:pharmacology*
D005449:Fluorenes; D007074:Immunoglobulin G; D003094:Collagen; D013994:Tilorone